Clinical Trial Update: Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating second-line therapy for recurrent bladder cancer. It compares hyperthermia with mitomycin C or Bacillus Calmette-Guerin to sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guerin (Bacillus Calmette-Guerin)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Cancer Research Campaign Clinical Trials Centre | Conditions: Bladder Cancer | Phase 3 | Status: UNKNOWN